Register
|
Sign in
Home
Colon & Rectum
Disease prevention
Inflammatory bowel disease
Liver/pancreas
Oesophagus
Small Intestine
Stomach
Go
Archive - November 2009
Doctors question FDA warning on clopidogrel/omeprazole interaction
(25/11/2009)
Cetuximab improves resectability of colorectal liver metastases
(25/11/2009)
PPIs not associated with osteoporosis
(25/11/2009)
Constipation may be a marker for early Parkinson disease
(25/11/2009)
Manufacturer defends sibutramine against FDA warning
(25/11/2009)
Colorectal cancer patients do better in private versus public hospitals
(25/11/2009)
Important news for newsletter subscribers
(11/11/2009)
Optical diagnosis of small polyps feasible
(11/11/2009)
Frequent reflux symptoms increase oesophageal cancer risk 6-fold
(11/11/2009)
Lower doses may improve outcomes in chronic disease
(11/11/2009)
New poo log
(11/11/2009)
Don't blame IBD for all GI symptoms
(10/11/2009)
Thiopurines linked to cancer risk in IBD
(10/11/2009)
Journals adopt unified approach to conflict of interest declarations
(03/11/2009)
Too much red tape means less hands-on for interns
(03/11/2009)
Back to archive
...
Most viewed articles this week
Duodenal morphometry more sensitive than Marsh grade
(01/09/2010)
GESA revokes commitment to host APDW 2011
(01/09/2010)
Australian assay determines hep C treatment response
(01/09/2010)
Australian IBD rates high
(01/09/2010)
Concern over rise in rectal cancer in young
(01/09/2010)
Recent comments
Kevin Hourigan
said "
GESA seems to be working hard and well with Infection Control guidelines in endoscopy units.It..."
Prof Thomas J Borody
said "
Dear Editor, I would like to correct a statement made by Tony James on his article..."
Related sites
6minutes
Australian Doctor
Cardiology Update
Endocrinology Update
Neurology Update
Oncology Update
Pharmacy News
Psychiatry Update
Rheumatology Update